• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性复发性流产主要由非整倍体胚胎引起。

Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos.

机构信息

NYU Fertility Center, New York, New York, USA.

出版信息

Fertil Steril. 2012 Sep;98(3):675-80. doi: 10.1016/j.fertnstert.2012.05.025. Epub 2012 Jun 7.

DOI:10.1016/j.fertnstert.2012.05.025
PMID:22683012
Abstract

OBJECTIVE

To determine any beneficial effects of preimplantation genetic screening (PGS) of all chromosomes by array comparative genomic hybridization (aCGH), with either day 3 or blastocyst biopsy, for idiopathic recurrent pregnancy loss (RPL) patients compared with their expected loss rate.

DESIGN

Case series report.

SETTING

Multiple fertility centers.

PATIENT(S): A total of 287 cycles of couples with idiopathic RPL (defined as two or more losses).

INTERVENTION(S): PGS was done with day 3 biopsy (n = 193) or blastocyst biopsy (n = 94), followed by analysis with aCGH.

MAIN OUTCOME MEASURE(S): Spontaneous abortion rate, euploidy rate.

RESULT(S): A total of 2,282 embryos were analyzed, of which 35% were euploid and 60% were aneuploid. There were 181 embryo transfer cycles, of which 100 (55%) became pregnant with an implantation rate of 45% (136 sacs/299 replaced embryos) and 94 pregnancies (92%) were ongoing (past second trimester) or delivered. The miscarriage rate was found to be only 6.9% (7/102), compared with the expected rate of 33.5% in an RPL control population and 23.7% in an infertile control population.

CONCLUSION(S): Current PGS results with aCGH indicate a significant decrease in the miscarriage rate of idiopathic RPL patients and high pregnancy rates. Furthermore, this suggests that idiopathic recurrent miscarriage is mostly caused by chromosomal abnormalities in embryos.

摘要

目的

通过比较基因组杂交(array comparative genomic hybridization,aCGH)对所有染色体进行植入前遗传学筛查(preimplantation genetic screening,PGS),以确定其对不明原因复发性妊娠丢失(idiopathic recurrent pregnancy loss,RPL)患者的有益影响,同时比较其预期丢失率。

设计

病例系列报告。

设置

多个生育中心。

患者

共有 287 个周期的不明原因 RPL 夫妇(定义为两次或两次以上流产)。

干预措施

进行 PGS 分析,使用的方法分别为第 3 天活检(n = 193)和囊胚活检(n = 94),然后进行 aCGH 分析。

主要观察指标

自然流产率、整倍体率。

结果

共分析了 2,282 个胚胎,其中 35%为整倍体,60%为非整倍体。共进行了 181 个胚胎移植周期,其中 100 个(55%)怀孕,着床率为 45%(136 个囊胚/299 个替换胚胎),94 个妊娠(92%)继续进行(超过第二个孕中期)或分娩。流产率仅为 6.9%(7/102),而 RPL 对照组的预期流产率为 33.5%,不孕对照组的预期流产率为 23.7%。

结论

目前的 aCGH PGS 结果表明,不明原因 RPL 患者的流产率显著降低,妊娠率较高。此外,这表明不明原因的复发性流产主要是由胚胎染色体异常引起的。

相似文献

1
Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos.特发性复发性流产主要由非整倍体胚胎引起。
Fertil Steril. 2012 Sep;98(3):675-80. doi: 10.1016/j.fertnstert.2012.05.025. Epub 2012 Jun 7.
2
Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.胚胎植入前遗传学检测非整倍体:胚胎非整倍体性复发性流产或反复着床失败患者活产率的比较。
Hum Reprod. 2019 Dec 1;34(12):2340-2348. doi: 10.1093/humrep/dez229.
3
Why do euploid embryos miscarry? A case-control study comparing the rate of aneuploidy within presumed euploid embryos that resulted in miscarriage or live birth using next-generation sequencing.整倍体胚胎为何会流产?一项病例对照研究,使用下一代测序技术比较导致流产或活产的假定整倍体胚胎中的非整倍体率。
Fertil Steril. 2016 Nov;106(6):1414-1419.e5. doi: 10.1016/j.fertnstert.2016.08.017. Epub 2016 Sep 28.
4
Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization.在卵巢储备功能下降的反复妊娠丢失患者中,行体外受精时囊胚非整倍体率较高,且胚胎移植失败风险较高。
Fertil Steril. 2016 Oct;106(5):1124-1128. doi: 10.1016/j.fertnstert.2016.06.016. Epub 2016 Jun 29.
5
Genetic diseases and aneuploidies can be detected with a single blastocyst biopsy: a successful clinical approach.通过单个胚胎活检可检测出遗传疾病和非整倍体:一种成功的临床方法。
Hum Reprod. 2017 Aug 1;32(8):1770-1777. doi: 10.1093/humrep/dex215.
6
Clinical outcomes after the transfer of blastocysts characterized as mosaic by high resolution Next Generation Sequencing- further insights.通过高分辨率下一代测序鉴定为嵌合的囊胚移植后的临床结局——进一步见解
Eur J Med Genet. 2020 Feb;63(2):103741. doi: 10.1016/j.ejmg.2019.103741. Epub 2019 Aug 21.
7
Intent to treat analysis of in vitro fertilization and preimplantation genetic screening versus expectant management in patients with recurrent pregnancy loss.复发性流产患者体外受精与植入前基因筛查对比期待治疗的意向性分析
Hum Reprod. 2016 Aug;31(8):1668-74. doi: 10.1093/humrep/dew135. Epub 2016 Jun 7.
8
Next generation sequencing for preimplantation genetic screening improves pregnancy outcomes compared with array comparative genomic hybridization in single thawed euploid embryo transfer cycles.与单枚解冻整倍体胚胎移植周期中的阵列比较基因组杂交相比,胚胎植入前遗传学筛查的新一代测序可改善妊娠结局。
Fertil Steril. 2018 Apr;109(4):627-632. doi: 10.1016/j.fertnstert.2017.12.017. Epub 2018 Mar 28.
9
Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts.标准囊胚形态、整倍体与着床的相关性:两个中心涉及 956 枚筛选囊胚的观察性研究。
Hum Reprod. 2014 Jun;29(6):1173-81. doi: 10.1093/humrep/deu033. Epub 2014 Feb 26.
10
Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.放下过去:女性的生殖史与囊胚的整倍体率无关,与整倍体胚胎移植后的活产率关联有限。
Hum Reprod. 2021 Mar 18;36(4):929-940. doi: 10.1093/humrep/deab014.

引用本文的文献

1
Preimplantation Testing of Human Blastomeres for Aneuploidy Increases IVF Success in Couples Where Male Partners Had Abnormal Semen Parameters.对人类卵裂球进行非整倍体植入前检测可提高男性伴侣精液参数异常的夫妇的体外受精成功率。
Biomedicines. 2025 May 13;13(5):1191. doi: 10.3390/biomedicines13051191.
2
From live birth to live birth: a strong correlation between the outcomes of first and second frozen-thawed euploid blastocyst transfers from sibling oocytes.从活产到活产:来自同胞卵母细胞的首次和第二次冻融整倍体囊胚移植结果之间存在强相关性。
J Assist Reprod Genet. 2025 Jan;42(1):193-200. doi: 10.1007/s10815-024-03329-w. Epub 2024 Nov 19.
3
Multi-omics PGT: re-evaluation of euploid blastocysts for implantation potential based on RNA sequencing.
多组学植入前基因检测:基于RNA测序对整倍体囊胚的着床潜力进行重新评估。
Hum Reprod. 2024 Dec 1;39(12):2861-2872. doi: 10.1093/humrep/deae237.
4
A review of artificial intelligence applications in in vitro fertilization.人工智能在体外受精中的应用综述。
J Assist Reprod Genet. 2025 Jan;42(1):3-14. doi: 10.1007/s10815-024-03284-6. Epub 2024 Oct 14.
5
Impact of blastocyst grading and blastocyst biopsy dates on the clinical outcomes of patients undergoing preimplantation genetic testing.囊胚评分和囊胚活检日期对接受胚胎植入前遗传学检测患者临床结局的影响。
Front Endocrinol (Lausanne). 2024 Sep 20;15:1427922. doi: 10.3389/fendo.2024.1427922. eCollection 2024.
6
Predicting Infertility: How Genetic Variants in Oocyte Spindle Genes Affect Egg Quality.预测不孕:卵母细胞纺锤体基因中的遗传变异如何影响卵子质量。
Adv Anat Embryol Cell Biol. 2024;238:1-22. doi: 10.1007/978-3-031-55163-5_1.
7
A systematic review and meta-analysis: clinical outcomes of recurrent pregnancy failure resulting from preimplantation genetic testing for aneuploidy.一项系统回顾和荟萃分析:胚胎植入前遗传学检测非整倍体所致复发性妊娠失败的临床结局。
Front Endocrinol (Lausanne). 2023 Oct 2;14:1178294. doi: 10.3389/fendo.2023.1178294. eCollection 2023.
8
Evaluation of pre-implantation genetic testing for aneuploidy outcomes in patients without infertility undergoing in vitro fertilization compared to infertile controls.对行体外受精而无不孕的患者与不孕对照相比,胚胎植入前遗传学检测非整倍体结果的评估。
J Assist Reprod Genet. 2023 Nov;40(11):2697-2704. doi: 10.1007/s10815-023-02941-6. Epub 2023 Sep 16.
9
Systematic review and meta-analysis: does pre-implantation genetic testing for aneuploidy at the blastocyst stage improve live birth rate?系统评价与荟萃分析:囊胚期胚胎非整倍体筛查能否提高活产率?
J Assist Reprod Genet. 2023 Oct;40(10):2297-2316. doi: 10.1007/s10815-023-02866-0. Epub 2023 Jul 22.
10
Correlation study of male semen parameters and embryo aneuploidy in preimplantation genetic testing for aneuploidy.植入前遗传学检测非整倍体中男性精液参数与胚胎非整倍体的相关性研究。
Front Endocrinol (Lausanne). 2023 Jan 26;13:1072176. doi: 10.3389/fendo.2022.1072176. eCollection 2022.